why choose us

First received: December 13, 2023

Clinical Trial: The STOP-MED CTRCD Trial

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Heart Failure

Study Type: INTERVENTIONAL


Official Title: A Multi-Centre Non-Inferiority Randomized Controlled Trial of STOPping Cardiac MEDications in Patients With Normalized Cancer Therapy Related Cardiac Dysfunction: The STOP-MED CTRCD Trial

Brief Summary: Cancer therapy-related cardiac dysfunction (CTRCD) is when the heart's ability to pump oxygenated blood to the body is compromised.It is a side effect of cancer therapy which can occur as commonly as in 1 in 5 patients.When this occurs, heart failure medications are started to protect the heart from progressing to heart failure.With early detection and treatment, heart function recovers to normal in >80% of patients.Unfortunately, heart failure medications are associated with an undesirable long-term pill…

Read more